Screening for cancer in viral hepatitis

Clinics in Liver Disease

Volumn 5, Issue 1, 2001, Pages 109-122

  Colombo, Massimo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; CANCER RISK; CANCER SCREENING; CHRONICITY; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOGRAPHY; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC DISORDER; REVIEW; RISK FACTOR; TUMOR GROWTH; VIRUS CARRIER; VIRUS HEPATITIS;

EID: 0035143883     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70156-2     Document Type: Article

References (60)

1. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival
2. Hepatitis B virus. The major etiology of hepatocellular carcinoma
3. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis: A prospective study
4. Small hepatocellular carcinomas in cirrhotic explant livers: Identification by macroscopic examination and Lipiodol localization
5. Ultrasonography-detected macroregenerative nodules in cirrhosis: A prospective study
6. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study
7. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis
8. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study
9. Hepatocellular carcinoma in Italian patients with cirrhosis
10. Early diagnosis of hepatocellular carcinoma in Italy: A summary of a Consensus Development Conference held in Milan, 16 November 1990 by the Italian Association for the Study of the Liver (AISF)
11. Hepatocellular carcinoma: Screening and treatment
12. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: An 8 year prospective study by ultrasound and alphafetoprotein
13. The natural history of asymptomatic hepatitis B surface antigen carriers
14. Detection of malignant tumors in end-stage cirrhotic livers: Efficacy of sonography as a screening technique
15. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
16. Hepatocellular carcinoma [letter]
17. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: A study in 22 patients
18. Rising incidence of hepatocellular carcinoma in the United States
19. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis due to multiple etiological factors
20. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
21. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B
22. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
23. Chronic type B hepatitis and the "healthy" HBsAg carrier state
24. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients
25. Small hepatic nodules in cirrhosis: Ultrasonographic, CT, and MR imaging findings
26. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers
27. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan
28. Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography
29. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis: A prospective study
30. No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis
31. Prognosis of hepatocellular carcinoma: The BCLC staging classification
32. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
33. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
34. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases
35. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
36. Workshop on screening for hepatocellular carcinoma
37. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska Native carriers
38. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma
39. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
40. Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma
41. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time: A preliminary report
42. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen
43. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
44. Screening for hepatocellular carcinoma in high-risk individuals
45. Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma
46. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective
47. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein
48. Hepatocellular carcinoma
49. Minus strand RNA of hepatitis C virus in liver tissues
50. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
51. Subclinical hepatocellular carcinoma-historical aspects and general considerations
52. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus positive cirrhotic patients
53. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C
54. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: A prospective study
55. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
56. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal
57. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical review
58. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience